Orikawa Y - Search Results

1

Peptidoglycan-Like Components in Z-100, Extracted from Mycobacterium tuberculosis Strain Aoyama B, Increase IL-12p40 via NOD2.

Horii T, Orikawa Y, Ohira Y, Eta R, Tominaga U, Sato T, Tanaka T. Horii T, et al. Among authors: orikawa y. J Immunol Res. 2022 Jun 22;2022:3530937. doi: 10.1155/2022/3530937. eCollection 2022. J Immunol Res. 2022. PMID: 35785036 Free PMC article.

2

Pharmacological evaluation of analgesic effects of the cholecystokinin2 receptor antagonist Z-360 in mouse models of formalin- and cancer-induced pain.

Yoshinaga K, Horii T, Hamano H, Eta R, Ozaki T, Orikawa Y, Yoshii K, Kawabata Y, Hori Y, Seto K, Takei M, Kuraishi Y. Yoshinaga K, et al. Among authors: orikawa y. Biol Pharm Bull. 2010;33(2):244-8. doi: 10.1248/bpb.33.244. Biol Pharm Bull. 2010. PMID: 20118547 Free article.

3

Z-100, an immunomodulatory extract of Mycobacterium tuberculosis strain Aoyama B, prevents spontaneous lymphatic metastasis of B16-BL6 melanoma.

Horii T, Yoshinaga K, Kobayashi N, Seto K, Orikawa Y, Okamoto M, Eta R, Ohira Y, Katsunuma K, Hori Y, Tanaka T, Takei M. Horii T, et al. Among authors: orikawa y. Biol Pharm Bull. 2014;37(4):642-7. doi: 10.1248/bpb.b13-00927. Biol Pharm Bull. 2014. PMID: 24818259

4

Potential of Z-100, extracted from Mycobacterium tuberculosis strain Aoyama B, as a hot tumor inducer.

Horii T, Orikawa Y, Ohira Y, Eta R, Kobayashi N, Sato T, Watanabe T, Tanaka T. Horii T, et al. Among authors: orikawa y. Cancer Cell Int. 2022 Dec 9;22(1):392. doi: 10.1186/s12935-022-02821-6. Cancer Cell Int. 2022. PMID: 36494701 Free PMC article.

5

Z-360, a novel cholecystokinin-2/gastrin receptor antagonist, inhibits gemcitabine-induced expression of the vascular endothelial growth factor gene in human pancreatic cancer cells.

Kobayashi N, Seto K, Orikawa Y, Hamano H, Yoshinaga K, Takei M. Kobayashi N, et al. Among authors: orikawa y. Biol Pharm Bull. 2010;33(2):216-22. doi: 10.1248/bpb.33.216. Biol Pharm Bull. 2010. PMID: 20118543 Free article.

6

Z-360, a novel therapeutic agent for pancreatic cancer, prevents up-regulation of ephrin B1 gene expression and phosphorylation of NR2B via suppression of interleukin-1 β production in a cancer-induced pain model in mice.

Orikawa Y, Kato H, Seto K, Kobayashi N, Yoshinaga K, Hamano H, Hori Y, Meyer T, Takei M. Orikawa Y, et al. Mol Pain. 2010 Oct 28;6:72. doi: 10.1186/1744-8069-6-72. Mol Pain. 2010. PMID: 20979661 Free PMC article.

7

A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice.

Shiomi Y, Yamauchi T, Iwabu M, Okada-Iwabu M, Nakayama R, Orikawa Y, Yoshioka Y, Tanaka K, Ueki K, Kadowaki T. Shiomi Y, et al. Among authors: orikawa y. J Biol Chem. 2015 Jun 5;290(23):14567-81. doi: 10.1074/jbc.M114.622191. Epub 2015 Apr 23. J Biol Chem. 2015. PMID: 25907553 Free PMC article.

8

Eel green fluorescent protein is associated with resistance to oxidative stress.

Funahashi A, Komatsu M, Furukawa T, Yoshizono Y, Yoshizono H, Orikawa Y, Takumi S, Shiozaki K, Hayashi S, Kaminishi Y, Itakura T. Funahashi A, et al. Among authors: orikawa y. Comp Biochem Physiol C Toxicol Pharmacol. 2016 Mar-Apr;181-182:35-9. doi: 10.1016/j.cbpc.2015.12.009. Epub 2015 Dec 30. Comp Biochem Physiol C Toxicol Pharmacol. 2016. PMID: 26746389

9

[Experimental studies on antineoplastic activity of daunomycin. I. Effect on experimental tumors].

Nomiya B, Kagino K, Orikawa Y, Fujimori H. Nomiya B, et al. Among authors: orikawa y. Jpn J Antibiot. 1970 Apr;23(2):171-80. Jpn J Antibiot. 1970. PMID: 5311043 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters